These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2711026)

  • 21. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusion.
    Earhart RH; Koeller JM; Davis TE; Borden EC; McGovren JP; Davis HL; Tormey DC
    Cancer Treat Rep; 1983; 67(7-8):683-92. PubMed ID: 6871883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
    Nichols KE; Chitneni SR; Moore JO; Weinberg JB
    Blood; 1989 Oct; 74(5):1728-37. PubMed ID: 2790198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
    Neil GL; Berger AE; McPartland RP; Grindey GB; Bloch A
    Cancer Res; 1979 Mar; 39(3):852-6. PubMed ID: 427775
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of L-glutamate and GABA on the response of expiratory neurons to mechanical loads.
    Toleikis JR; Frazier DT
    J Neurosci Res; 1982; 7(4):443-52. PubMed ID: 6128426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholamine-independent behavioral and neurochemical effects of cocaine in rats.
    Gale K
    NIDA Res Monogr; 1984; 54():323-32. PubMed ID: 6099878
    [No Abstract]   [Full Text] [Related]  

  • 27. Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats.
    Tang AH; Franklin SR
    J Pharmacol Exp Ther; 1983 Jun; 225(3):503-8. PubMed ID: 6864515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral effects of vigabatrin correlated with whole brain gamma-aminobutyric acid metabolism in audiogenic sensitive rats.
    Engelborghs S; Pickut BA; D'Hooge R; Wiechert P; Haegele K; De Deyn PP
    Arzneimittelforschung; 1998 Jul; 48(7):713-6. PubMed ID: 9706369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.
    Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR
    Neuropharmacology; 2007 Jul; 53(1):113-24. PubMed ID: 17559891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single unit responses of substantia nigra and globus pallidus neurons to GABA agonist and antagonist drugs.
    Waszczak BL; Bergstrom DA; Walters JR
    Adv Biochem Psychopharmacol; 1981; 30():79-94. PubMed ID: 7331938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins.
    Yenkoyan K; Safaryan K; Navasardyan G; Mkrtchyan L; Aghajanov M
    Neurochem Int; 2009; 54(5-6):292-8. PubMed ID: 19121356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary pharmacological investigation on 38 aminophosphonic acids and their derivatives.
    Kleinrok Z; Kolasa K; Chodkowska A; Mastalerz P; Kafarski P
    Pol J Pharmacol Pharm; 1985; 37(5):575-84. PubMed ID: 3008130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acivicin on glutamine transport by rat renal brush border membrane vesicles.
    Sastrasinh S; Sastrasinh M
    J Lab Clin Med; 1986 Oct; 108(4):301-8. PubMed ID: 2876045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier-mediated transport of the antitumor agent acivicin across the blood-brain barrier.
    Chikhale EG; Chikhale PJ; Borchardt RT
    Biochem Pharmacol; 1995 Mar; 49(7):941-5. PubMed ID: 7741766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme targets of antiglutamine agents in cancer chemotherapy.
    Prajda N
    Adv Enzyme Regul; 1985; 24():207-23. PubMed ID: 2424283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of tumor growth following treatment with a glutamine antimetabolite.
    Chance WT; Cao L; Kim MW; Nelson JL; Fischer JE
    Life Sci; 1988; 42(1):87-94. PubMed ID: 3336272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phencyclidine-like behavioral effects of 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP).
    Tang AH; Cangelosi AA; Code RA; Franklin SR
    Pharmacol Biochem Behav; 1984 Feb; 20(2):209-13. PubMed ID: 6718449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation by acivicin of rat brain CTP and GMP synthetases and depression of CTP and GTP concentrations.
    Achleitner E; Lui MS; Weber G
    Adv Enzyme Regul; 1985; 24():225-32. PubMed ID: 3835820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropharmacological effects of methotrexate perfused through the cerebrospinal fluid system of the rhesus monkey.
    Shepard RF; Merker PC; Walker MD; Gilles FH
    Cancer Res; 1976 Oct; 36(10):3771-8. PubMed ID: 821606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.